Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Document Medication Side Effect Monitoring

Monroe, Louisiana Survey Completed on 12-11-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident’s drug regimen was free from unnecessary medications by not consistently documenting the required monitoring for side effects of anticoagulant and anticonvulsant medications. The resident, who had a history of hemiplegia and hemiparesis following a cerebral infarction, atrial fibrillation, atherosclerotic heart disease, hypertensive heart disease with heart failure, seizures, and diabetes mellitus, was prescribed Eliquis (an anticoagulant) and Levetiracetam (an anticonvulsant). Physician orders required monitoring for side effects of these medications every shift, and the resident’s care plan included interventions to monitor and document side effects and effectiveness of the medications. Record reviews revealed that the facility failed to document the required monitoring for side effects on multiple occasions in both November and December. Specifically, there was no documented evidence of monitoring for 13 instances in November and 5 instances in December, despite the resident receiving both medications during these periods. Interviews with nursing staff confirmed that the monitoring was not documented as ordered while the resident was on these medications.

An unhandled error has occurred. Reload 🗙